KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Restructuring Costs (2021 - 2025)

LifeMD's Restructuring Costs history spans 4 years, with the latest figure at $27.8 million for Q4 2025.

  • For Q4 2025, Restructuring Costs rose 269.0% year-over-year to $27.8 million; the TTM value through Dec 2025 reached $47.3 million, up 153.2%, while the annual FY2025 figure was $32.0 million, 16.08% up from the prior year.
  • Restructuring Costs reached $27.8 million in Q4 2025 per LFMD's latest filing, up from $1.4 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $27.8 million in Q4 2025 to a low of $20896.0 in Q2 2021.
  • Average Restructuring Costs over 4 years is $6.6 million, with a median of $4.4 million recorded in 2024.
  • The largest YoY upside for Restructuring Costs was 431.68% in 2025 against a maximum downside of 7.86% in 2025.
  • A 4-year view of Restructuring Costs shows it stood at $20896.0 in 2021, then soared by 118.51% to $45659.0 in 2022, then surged by 16386.31% to $7.5 million in 2024, then soared by 269.0% to $27.8 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Restructuring Costs are $27.8 million (Q4 2025), $1.4 million (Q3 2025), and $10.9 million (Q2 2025).